logo
Nachawati Law Group Files New Ovarian Cancer Lawsuits Against Johnson & Johnson After Latest Bankruptcy Ploy Fails

Nachawati Law Group Files New Ovarian Cancer Lawsuits Against Johnson & Johnson After Latest Bankruptcy Ploy Fails

Business Wire15-05-2025
DALLAS--(BUSINESS WIRE)--Following a third failed bankruptcy maneuver by Johnson & Johnson (NYSE: JNJ), trial lawyers with Dallas-based Nachawati Law Group have filed three new lawsuits on behalf of women who developed cancer after prolonged use of the company's talc-based products.
The filings come as courts across the country prepare to restart proceedings in one of the largest mass torts in U.S. history after a federal bankruptcy judge dismissed J&J's third attempt to shield itself from litigation through a controversial bankruptcy ploy. More than 50,000 women allege they developed ovarian cancer or other gynecological cancers from long-term use of Johnson's Baby Powder and other products.
'Our recent talc ovarian cancer filings in DC and Florida are direct messages to Johnson & Johnson and the sellers of talc-based products, of our willingness and eagerness to resume the fight on behalf of our clients against the corporate malfeasances that have harmed our clients and resulted in their tragic cancer diagnoses,' said trial lawyer Charlie Stern. 'After waiting many years to resume this fight as the sham J&J bankruptcies worked their way through the courts and were eventually all dismissed, we anticipate filing more cases like these in states around the country to hold these bad actors accountable for their decades worth of nefarious activities.'
J&J's proposed settlement, which was part of its third attempt to use the so-called 'Texas Two-Step' legal maneuver, was rejected by U.S. Bankruptcy Judge Christopher Lopez, who cited problems with the claimants' voting process and found the plan improperly sought to extend legal protections to non-debtor entities, shielding them from future liability without the consent of all affected plaintiffs.
'For far too long, Johnson & Johnson has used the bankruptcy system as a tool to delay and deny justice,' said firm founder Majed Nachawati. 'The courthouse doors are open again, and we are walking through them. Our clients have a constitutional right to be heard, and we intend to make sure that happens.'
Nachawati Law Group represents thousands of women nationwide who developed ovarian cancer after using Johnson's Baby Powder and other talc-based products that internal company documents have shown may be contaminated with asbestos. The firm has consistently fought for accountability, both in court and in good-faith discussions to resolve claims.
About Nachawati Law Group
Nachawati Law Group represents individuals in mass tort litigation, businesses and governmental entities in contingent litigation and individual victims in complex personal injury litigation. For more information, visit https://ntrial.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UnitedHealth Group's (UNH) Healthcare Dominance: A Key Player in the Dogs of the Dow
UnitedHealth Group's (UNH) Healthcare Dominance: A Key Player in the Dogs of the Dow

Yahoo

time11 minutes ago

  • Yahoo

UnitedHealth Group's (UNH) Healthcare Dominance: A Key Player in the Dogs of the Dow

UnitedHealth Group Incorporated (NYSE:UNH) is included among the 11 Dogs of the Dow Dividend Stocks to Buy Now. A senior healthcare professional giving advice to a patient in a clinic. The stock has dropped over 44% so far this year after reporting weaker-than-expected earnings in the first quarter. The company first reduced its full-year outlook and later chose to withdraw it entirely. Even with the underwhelming Q1 performance, UnitedHealth Group Incorporated (NYSE:UNH) still posted a 9.8% year-over-year increase in revenue, reaching $109.6 billion. It earned a profit of around $6.3 billion during the quarter and maintained a solid financial position, holding close to $34.3 billion in cash and cash equivalents, along with a debt level that remains manageable. The company has added 780,000 new members so far this year. Meanwhile, Optum Health still expects to provide value-based care to an additional 650,000 patients in 2025. In addition, UnitedHealth Group Incorporated (NYSE:UNH) generated $5.5 billion in operating cash flow during the quarter and returned $5 billion to investors through dividends and share repurchases. The company has been rewarding shareholders with growing dividends since 2011 and currently offers a quarterly dividend of $2.21 per share. The stock supports a dividend yield of 3.15%, as of July 26. While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Why Yield-Focused Investors Favor Chevron (CVX) in the Dogs of the Dow Portfolio
Why Yield-Focused Investors Favor Chevron (CVX) in the Dogs of the Dow Portfolio

Yahoo

time11 minutes ago

  • Yahoo

Why Yield-Focused Investors Favor Chevron (CVX) in the Dogs of the Dow Portfolio

Chevron Corporation (NYSE:CVX) is included among the 11 Dogs of the Dow Dividend Stocks to Buy Now. An aerial view of an oil rig at sea, the sun glinting off its structure. It is currently facing some company-specific challenges, including a complicated merger and operations in politically unstable regions. However, these issues are unlikely to affect its long-term prospects. Income-focused investors can generally feel confident investing in Chevron. Chevron Corporation (NYSE:CVX)'s integrated business model, covering everything from exploration and production to refining and chemicals, offers operational flexibility and acts as a natural hedge against fluctuations in energy prices, enhancing its resilience through market cycles. Unlike many competitors who chase volume growth, Chevron takes a disciplined approach, investing only in its highest-return projects, avoiding overexpansion during booms, and making strategic, value-adding acquisitions. This strategy, along with a strong balance sheet, establishes Chevron Corporation (NYSE:CVX) as a leading operator with the financial strength to endure downturns and seize growth opportunities. The company has been growing its dividends for 38 consecutive years and currently offers a quarterly dividend of $1.71 per share. As of July 26, the stock has a dividend yield of 4.42%. While we acknowledge the potential of CVX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.

Coca-Cola's (KO) Timeless Appeal Among the Dogs of the Dow
Coca-Cola's (KO) Timeless Appeal Among the Dogs of the Dow

Yahoo

time11 minutes ago

  • Yahoo

Coca-Cola's (KO) Timeless Appeal Among the Dogs of the Dow

The Coca-Cola Company (NYSE:KO) is included among the 11 Dogs of the Dow Dividend Stocks to Buy Now. A row of factory workers assembling bottles of sparkling soft drinks on a conveyor belt. The stock has surged by nearly 12% since the start of 2025, outperforming the broader market. Investors have shown strong interest in the stock this year for a number of reasons. It's often seen as a safe choice during market downturns because of its stability, making it a popular pick when uncertainty rises. More recently, confidence in The Coca-Cola Company (NYSE:KO) has been boosted by its strong position against potential tariff impacts. In addition, the company reported strong earnings in the second quarter of 2025. Its revenue came in at $12.6 billion, up 1% from the same period last year. The revenue beat analysts' estimates by $42 million. Operating income rose by 63%, while on a comparable currency-neutral basis (non-GAAP), it saw a 15% increase. The Coca-Cola Company (NYSE:KO) also remains investors' favorite because the company has been growing its payouts for 63 consecutive years. The company pays a quarterly dividend of $0.51 per share and has a dividend yield of 2.95%, as of July 26. While we acknowledge the potential of KO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store